Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I radiotherapy plus panitumumab bladder preservation trial
NL-OMON34833Active, not recruiting
- Sponsor
- Netherlands Cancer Institute
- Start
- Jan 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Trial of panitumumab, sponsored by Netherlands Cancer Institute. Started Jan 2011; status: active, not recruiting.
02
Drugs
panitumumab
Beyond the preview
Go deeper on NL-OMON34833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34833.